Astrazeneca Pharma India Q4 Results Live : profit rise by 128.61% YOY
Astrazeneca Pharma India Q4 Results Live : Revenue increased by 34.6% YoY & profit increased by 128.61% YoY
Stay updated with breaking news from Pharma India. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Astrazeneca Pharma India Q4 Results Live : Revenue increased by 34.6% YoY & profit increased by 128.61% YoY
The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS).
Astrazeneca Pharma India Q3 FY24 Results Live : Revenue increased by 22.41% YoY & profit decreased by 46.08% YoY
This is the last trading week for the stock market this year. So will the year end on a happy note? Check out what the day can have in store, , stock market today, gold prices, silver prices, nse nifty, bse sensex
BSE's Sensex jumped 241.86 points, or 0.34 per cent, to settle at 71,106.96. NSE's Nifty50 gained 76.25 points, or 0.36 per cent, to end the day at 21,331.30 for the day.